Target intelligence / Profile preview

Hyphal wall protein 1 (HWP1) (HWP1)

Target
HWP1
Molecular classification
Adhesin, Cell wall protein, Glycoprotein, Transglutaminase substrate
01

Overview

Hyphal wall protein 1 (HWP1) is a major cell surface adhesin and critical virulence factor uniquely expressed during the hyphal (filamentous) phase of the opportunistic pathogen Candida albicans [1, 5, 7]. It functions as a specialized substrate for mammalian transglutaminases, enabling the fungus to form covalent isopeptide bonds with host epithelial cells, effectively 'tethering' the pathogen to host tissues with the same strength as native host protein interactions [2, 4, 12]. This covalent attachment is essential for the establishment of mucosal infections, such as oral and esophageal candidiasis, and is a key driver in the formation and structural integrity of fungal biofilms on both biological surfaces and medical devices like catheters [2, 3, 9]. Due to its surface accessibility and vital role in pathogenesis, HWP1 is a primary target for the development of novel antifungal vaccines, therapeutic antibodies, and diagnostic markers for invasive candidiasis [1, 8, 13]. While HWP1 is highly specific to the hyphal form, its sequence shares partial homology with gluten-derived gliadin, leading to hypotheses regarding its potential role in triggering or exacerbating Celiac disease through molecular mimicry [5, 15]. Therapeutic strategies targeting HWP1 aim to disrupt the fungal-host interface and prevent the biofilm-mediated resistance and dissemination characteristic of chronic and systemic Candida infections [2, 9, 14].

Other names
Hwp1pAdhesin HWP1Candida albicans HWP1Hyphal wall protein
02

Mechanism of action

Inhibition of fungal adhesion to host tissues, disruption of biofilm structural integrity, and induction of protective humoral and cellular immunity through vaccination.

03

Biological functions

Cell adhesionBiofilm formationHyphal morphogenesisCovalent host-cell cross-linkingFungal mating
04

Disease associations

CandidiasisOral candidiasisVulvovaginal candidiasisEsophageal candidiasisSystemic candidiasisBiofilm-associated infection
05

Safety considerations

Molecular mimicry with gliadin (potential cross-reactivity in Celiac disease)Morphology-specific expression (expressed only in hyphae, not yeast forms)Immune evasion through protein variability
06

Interacting drugs

Cytochalasin A

3 more in the full profile.

07

Biomarkers

HWP1 mRNA levelsHWP1 protein detectionAnti-HWP1 IgG antibody titersAnti-HWP1 IgA antibody titers

Beyond the preview

Go deeper on Hyphal wall protein 1 (HWP1) (HWP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyphal wall protein 1 (HWP1) (HWP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call